ArticleFrontiers in public health2025
Differential metabolic responses of mouse Leydig and spermatogonia cells to radiofrequency electromagnetic field exposure.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Although existing studies have shown that radiofrequency electromagnetic fields (RF-EMFs) have a variety of effects on living organisms, the specific impact of RF-EMFs on the metabolism of reproductive cells and their underlying mechanisms remain unclear.This study aims to explore the effects of RF-EMFs on the metabolism of mouse Leydig cells (TM3) and spermatogonia cells (GC-1) through metabolomics analysis, revealing the potential mechanisms by which RF-EMFs affect reproductive health. Methods: We employed liquid chromatography-mass spectrometry (LC-MS) to analyze the metabolomic profiles of TM3 and GC-1 cells under two irradiation modalities: continuous and intermittent RF-EMF exposure. The data were further analyzed using KEGG pathway analysis to identify significantly enriched metabolic pathways. The ELISA (Enzyme-Linked Immunosorbent Assay) was used to detect glutathione levels. Results: Our results showed that continuous irradiation had a more pronounced impact on the metabolism of TM3 cells, primarily affecting amino acid metabolism, the citric acid cycle, ABC transporters, bile secretion, and glutathione metabolism. In contrast, intermittent irradiation mainly altered the levels of fatty acyls and purine nucleosides, with significant enrichment in purine metabolism, biosynthesis of unsaturated fatty acids, and fatty acid metabolism. Compared to TM3 cells, GC-1 cells exhibited lower sensitivity to RF-EMF irradiation. Both irradiation modalities affected purine metabolism and lysine degradation pathways in TM3 cells, suggesting that changes in ADP levels may serve as a key metabolic signature in the cellular response to RF-EMF exposure. Conclusion: Continuous irradiation significantly impacts TM3 cell metabolism, particularly amino acid and glutathione pathways, while intermittent irradiation mainly affects fatty acyls and purine metabolism. GC-1 cells show lower sensitivity to RF-EMF. ADP level changes may be a key metabolic signature of RF-EMF exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.